Active member of ESMO, EORTC Head and Neck Group, and MASCC (chair of the Mucositis group).
He is involved in all institutional and national/international research activities on head and neck cancer, from translational research (gene expression, next generation sequencing) to assessment of quality of life and value-based medicine. He is particularly dedicated to rare cancer among head and neck ones (paranasal sinus cancer, adnexal cancer, nasopharyngeal cancer, salivary gland cancer). He has strong experience in conducting trials with targeted therapy and immunotherapy. He has a strong commitment to supportive care, both in clinical research and at education level, with a focus on treatment of elderly cancer patients and toxicities induced by immunotherapy. He is the Principal Investigator and co-investigator of several Italian and International trial on Head and Neck cancer. Authors of 251 publications indexed on PubMed.